What is it about?
This prospective study documents that blood pressure during sleep, but not during awakening of measurements obtained at the clinic, is a significant prognostic marker for the risk of developing chronic kidney disease (CKD). It also documents for the first time that decreasing sleep-time blood pressure actually reduces the risk for CKD.
Featured Image
Why is it important?
The results provide, first, a method to quantify the individualized risk for CKD based on the determination of sleep-time blood pressure by ambulatory monitoring, the already recommended approach for proper diagnosis of hypertension; and second, a way to reduce such risk by specifically targeting sleep-time blood pressure by proper timed therapeutic intervention.
Perspectives
These findings, if confirmed and extended to other populations, might provide a proper method for preventing the development and progression of CKD, a highly prevalent condition.
Ramon Hermida
Universidade de Vigo
Read the Original
This page is a summary of: Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD, Journal of the American Society of Nephrology, April 2017, American Society of Nephrology,
DOI: 10.1681/asn.2016111186.
You can read the full text:
Contributors
The following have contributed to this page







